# Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

> **NCT00004895** · PHASE2 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Colorectal Cancer
- Constipation, Impaction, and Bowel Obstruction
- Extrahepatic Bile Duct Cancer
- Gastric Cancer
- Gastrointestinal Stromal Tumor
- Nausea and Vomiting
- Ovarian Cancer
- Pancreatic Cancer
- Peritoneal Cavity Cancer
- Small Intestine Cancer

## Interventions

- **DRUG:** octreotide acetate

## Key facts

- **NCT ID:** NCT00004895
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2002-10
- **Final completion:** 2002-10
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004895, "Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*